[시장보고서]세계의 발열성 물질(파이로젠) 시험 시장 규모, 점유율 및 동향 분석 보고서 : 제품 및 서비스별, 테스트 유형별, 최종 사용자별, 지역별, 전망 및 예측(2023-2030년)

세계의 발열성 물질(파이로젠) 시험 시장 규모, 점유율 및 동향 분석 보고서 : 제품 및 서비스별, 테스트 유형별, 최종 사용자별, 지역별, 전망 및 예측(2023-2030년)

Global Pyrogen Testing Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Kits, Services, and Instruments), By Test Type (LAL Test, Rabbit Pyrogen Test, and Others), By End User, By Regional Outlook and Forecast, 2023 - 2030

상품코드 : 1432737 해당 상품은 즉시 배송 가능합니다

리서치사 : KBV Research

발행일 : 2024년 02월

페이지 정보 : 영문 216 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,600

￦ 5,197,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320

￦ 6,237,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048

￦ 8,732,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

발열성 물질(파이로젠) 시험 시장 규모는 2030년까지 26억 달러에 달할 것으로 예상되며, 예측 기간 동안 7.9%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

또한, 팬데믹(세계적 대유행) 기간 동안 의료 시스템에 가해진 전례 없는 수요로 인해 자원의 우선순위가 재조정되었습니다. 많은 제약 및 의료기기 회사가 코로나19 관련 제품의 개발, 생산 및 유통에 집중하면서 검사를 포함한 일상적인 품질 관리 프로세스에 대한 관심에 영향을 미쳤습니다. 또한 전염병은 다양한 산업 분야에서 기술 솔루션의 채택을 가속화했습니다. 시장에서는 전염병으로 인한 혼란에도 불구하고 검사 프로세스의 연속성과 효율성을 보장하기 위해 자동화, 디지털화 및 원격 모니터링 솔루션에 대한 관심이 높아졌습니다. 따라서 코로나19 팬데믹은 시장에 적당한 영향을 미쳤습니다.

그러나 고급 검사법에는 특수 장비가 필요할 수 있으며, 이를 구입하고 유지하는 데 비용이 많이 듭니다. 여기에는 내독소 검사 시스템, 분광광도계 및 기타 분석 장비와 같은 장비가 포함되며, 이는 검사 시설을 설치하는 데 드는 전체 비용에 기여합니다. 이 검사를 위해 숙련된 전문가를 고용하고 확보하는 데는 비용이 많이 들고, 중소기업은 유능한 인재를 확보하기 위해 경쟁해야 합니다. 따라서 이러한 요인들은 향후 몇 년동안 이 검사에 대한 수요를 감소시킬 것으로 보입니다.

북미 시장
- 북미 시장 : 제품 및 서비스별
- 북미 시장 : 시험 유형별
- 북미 시장 : 최종사용자별
- 북미 시장 : 국가별
유럽 시장
- 유럽 시장 : 제품 및 서비스별
- 유럽 시장 : 시험 유형별
- 유럽 시장 : 최종사용자별
- 유럽 시장 : 국가별
아시아태평양 시장
- 아시아태평양 시장 : 제품 및 서비스별
- 아시아태평양 시장 : 시험 유형별
- 아시아태평양 시장 : 최종사용자별
- 아시아태평양 시장 : 국가별
라틴아메리카/중동 및 아프리카 시장
- 라틴아메리카/중동 및 아프리카 시장 : 제품 및 서비스별
- 라틴아메리카/중동 및 아프리카 시장 : 시험 유형별
- 라틴아메리카/중동 및 아프리카 시장 : 최종사용자별
- 라틴아메리카/중동 및 아프리카 시장 : 국가별

제8장 기업 개요

Merck KGaA
Charles River Laboratories International, Inc
Genscript Biotech Corporation
WuXi AppTec Co, Ltd.
Lonza Group Ltd
Fujifilm Holdings Corporation
Eurofins Scientific SE
Thermo Fisher Scientific, Inc
Seikagaku Corp
InvivoGen SAS

제9장 발열성 물질(파이로젠) 시험 시장을 위한 성공 필수 조건

LSH

영문 목차

영문목차

The Global Pyrogen Testing Market size is expected to reach $2.6 billion by 2030, rising at a market growth of 7.9% CAGR during the forecast period.

Europe has a well-established regulatory framework for pharmaceutical and medical device industries. The European Medicines Agency (EMA) and other national agencies' implementation of rigorous regulatory standards to guarantee adherence to quality and safety protocols propels the need for this testing. Consequently, the Europe region would acquire nearly, 30% of the total market share by 2030. Additionally, the EU has been witnessing advancements in the biopharmaceutical sector, focusing on biologics, biosimilars, and gene therapies. These complex and novel products often require sophisticated testing methodologies, driving the need for expanded testing capabilities. Hence, the segment will witness increased demand in the upcoming years.

Pyrogens, particularly bacterial endotoxins, can cause adverse reactions in humans. Regulatory agencies mandate that pharmaceuticals and medical devices are free from pyrogens to ensure patient safety. This testing is conducted to detect and quantify the presence of pyrogens in products. Moreover, products are often subjected to sterilization procedures in the pharmaceutical and medical device manufacturing processes. Validation of these processes, including the absence of pyrogens post-sterilization, is crucial. Therefore, these factors will help in the expansion of the market. Additionally, the rise in chronic diseases necessitates the development of a diverse range of pharmaceuticals, including traditional small-molecule drugs, biologics, and medical devices. Each of these modalities undergoes extensive testing to ensure product safety, and this testing is one of the critical tests to detect potential contaminants. Moreover, chronic diseases often require long-term or frequent treatments, making patient safety paramount. Pyrogens, particularly bacterial endotoxins, can lead to severe adverse reactions. Rigorous testing helps mitigate these risks by ensuring the products intended for chronic disease management are free from harmful contaminants. Thus, these factors will assist in the growth of the market.

Moreover, the unprecedented demands placed on healthcare systems during the pandemic led to a reprioritization of resources. Many pharmaceutical and medical device companies directed their focus and resources toward developing, producing, and distributing COVID-19 related products, affecting the attention given to routine quality control processes, including this testing. Moreover, the pandemic accelerated the adoption of technological solutions in various industries. In the market, there was a heightened interest in automation, digitalization, and remote monitoring solutions to ensure continuity and efficiency in testing processes despite disruptions caused by the pandemic. Thus, the COVID-19 pandemic moderately impacted the market.

However, advanced testing methods may require specialized equipment, which can be expensive to acquire and maintain. This includes instruments such as endotoxin testing systems, spectrophotometers, and other analytical devices contributing to the overall cost of setting up a testing facility. In addition, conducting this testing, especially with advanced methods, requires personnel with specialized knowledge and skills. Hiring and retaining skilled professionals in this testing can be costly, and smaller companies may find it challenging to compete for qualified talent. Thus, these factors will decrease the demand for this testing in the upcoming years.

By Product & Service Analysis

Based on product & service, the market is segmented into reagents & kits, instruments, and services. In 2022, the instruments segment garnered a significant revenue share in the market. The progression of technology has resulted in the creation of sophisticated instruments utilized in this testing. Innovative technologies, such as automated liquid handling systems, microfluidics, and sophisticated detection techniques, have enhanced pyrogen detection methods' sensitivity, accuracy, and efficiency. Hence, the segment will witness increased demand in the coming years.

By Test Type Analysis

On the basis of test type, the market is divided into LAL test, rabbit pyrogen test, and others. In 2022, the others segment witnessed a substantial revenue share in the market. The "others" category in the context of this testing may include emerging technologies, innovative testing methods, or specific applications that do not fit within the conventional categories, like Limulus amebocyte lysate (LAL) testing or monocyte activation testing (MAT). Therefore, owing to these factors, the segment will witness enhanced growth in the upcoming years.

By End User Analysis

Based on end user, the market is divided into pharmaceutical & biotechnology companies, medical device companies, and others. In 2022, the medical device companies segment witnessed a substantial revenue share in the market. Ongoing advancements in the testing technologies, including more sensitive and efficient methods, may attract medical device companies looking to adopt state-of-the-art testing solutions. Improved testing technologies can offer quicker and more accurate results, contributing to medical devices' overall safety and quality. Therefore, the segment will grow rapidly in the coming years.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. The pharmaceutical and biotechnology sectors in North America have been consistently growing. The region is a hub for research and development activities, leading to the development of new drugs, biologics, and medical devices. The need for rigorous testing, including this testing, grows in tandem as the industry expands. Therefore, these factors will boost the demand in the segment.

List of Key Companies Profiled

Merck KGaA
Charles River Laboratories International, Inc.
Genscript Biotech Corporation
WuXi AppTec Co., Ltd.
Lonza Group Ltd.
Fujifilm Holdings Corporation
Eurofins Scientific SE
Thermo Fisher Scientific, Inc.
Seikagaku Corp.
InvivoGen SAS

Global Pyrogen Testing Market Report Segmentation

By Product & Service

Reagents & Kits
Services
Instruments

By Test Type

LAL Test
Rabbit Pyrogen Test
Others

By End User

Pharmaceutical & Biotechnology Companies
Medical Device Companies
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Pyrogen Testing Market, by Product & Service
- 1.4.2 Global Pyrogen Testing Market, by Test Type
- 1.4.3 Global Pyrogen Testing Market, by End User
- 1.4.4 Global Pyrogen Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Global Pyrogen Testing Market, by Product & Service

4.1 Global Reagents & Kits Market, by Region
4.2 Global Services Market, by Region
4.3 Global Instruments Market, by Region

Chapter 5. Global Pyrogen Testing Market, by Test Type

5.1 Global LAL Test Market, by Region
5.2 Global Rabbit Pyrogen Test Market, by Region
5.3 Global Others Market, by Region

Chapter 6. Global Pyrogen Testing Market, by End User

6.1 Global Pharmaceutical & Biotechnology Companies Market, by Region
6.2 Global Medical Device Companies Market, by Region
6.3 Global Others Market, by Region

Chapter 7. Global Pyrogen Testing Market, by Region

7.1 North America Pyrogen Testing Market
- 7.1.1 North America Pyrogen Testing Market, by Product & Service
  - 7.1.1.1 North America Reagents & Kits Market, by Country
  - 7.1.1.2 North America Services Market, by Country
  - 7.1.1.3 North America Instruments Market, by Country
- 7.1.2 North America Pyrogen Testing Market, by Test Type
  - 7.1.2.1 North America LAL Test Market, by Country
  - 7.1.2.2 North America Rabbit Pyrogen Test Market, by Country
  - 7.1.2.3 North America Others Market, by Country
- 7.1.3 North America Pyrogen Testing Market, by End User
  - 7.1.3.1 North America Pharmaceutical & Biotechnology Companies Market, by Country
  - 7.1.3.2 North America Medical Device Companies Market, by Country
  - 7.1.3.3 North America Others Market, by Country
- 7.1.4 North America Pyrogen Testing Market, by Country
  - 7.1.4.1 US Pyrogen Testing Market
    - 7.1.4.1.1 US Pyrogen Testing Market, by Product & Service
    - 7.1.4.1.2 US Pyrogen Testing Market, by Test Type
    - 7.1.4.1.3 US Pyrogen Testing Market, by End User
  - 7.1.4.2 Canada Pyrogen Testing Market
    - 7.1.4.2.1 Canada Pyrogen Testing Market, by Product & Service
    - 7.1.4.2.2 Canada Pyrogen Testing Market, by Test Type
    - 7.1.4.2.3 Canada Pyrogen Testing Market, by End User
  - 7.1.4.3 Mexico Pyrogen Testing Market
    - 7.1.4.3.1 Mexico Pyrogen Testing Market, by Product & Service
    - 7.1.4.3.2 Mexico Pyrogen Testing Market, by Test Type
    - 7.1.4.3.3 Mexico Pyrogen Testing Market, by End User
  - 7.1.4.4 Rest of North America Pyrogen Testing Market
    - 7.1.4.4.1 Rest of North America Pyrogen Testing Market, by Product & Service
    - 7.1.4.4.2 Rest of North America Pyrogen Testing Market, by Test Type
    - 7.1.4.4.3 Rest of North America Pyrogen Testing Market, by End User
7.2 Europe Pyrogen Testing Market
- 7.2.1 Europe Pyrogen Testing Market, by Product & Service
  - 7.2.1.1 Europe Reagents & Kits Market, by Country
  - 7.2.1.2 Europe Services Market, by Country
  - 7.2.1.3 Europe Instruments Market, by Country
- 7.2.2 Europe Pyrogen Testing Market, by Test Type
  - 7.2.2.1 Europe LAL Test Market, by Country
  - 7.2.2.2 Europe Rabbit Pyrogen Test Market, by Country
  - 7.2.2.3 Europe Others Market, by Country
- 7.2.3 Europe Pyrogen Testing Market, by End User
  - 7.2.3.1 Europe Pharmaceutical & Biotechnology Companies Market, by Country
  - 7.2.3.2 Europe Medical Device Companies Market, by Country
  - 7.2.3.3 Europe Others Market, by Country
- 7.2.4 Europe Pyrogen Testing Market, by Country
  - 7.2.4.1 Germany Pyrogen Testing Market
    - 7.2.4.1.1 Germany Pyrogen Testing Market, by Product & Service
    - 7.2.4.1.2 Germany Pyrogen Testing Market, by Test Type
    - 7.2.4.1.3 Germany Pyrogen Testing Market, by End User
  - 7.2.4.2 UK Pyrogen Testing Market
    - 7.2.4.2.1 UK Pyrogen Testing Market, by Product & Service
    - 7.2.4.2.2 UK Pyrogen Testing Market, by Test Type
    - 7.2.4.2.3 UK Pyrogen Testing Market, by End User
  - 7.2.4.3 France Pyrogen Testing Market
    - 7.2.4.3.1 France Pyrogen Testing Market, by Product & Service
    - 7.2.4.3.2 France Pyrogen Testing Market, by Test Type
    - 7.2.4.3.3 France Pyrogen Testing Market, by End User
  - 7.2.4.4 Russia Pyrogen Testing Market
    - 7.2.4.4.1 Russia Pyrogen Testing Market, by Product & Service
    - 7.2.4.4.2 Russia Pyrogen Testing Market, by Test Type
    - 7.2.4.4.3 Russia Pyrogen Testing Market, by End User
  - 7.2.4.5 Spain Pyrogen Testing Market
    - 7.2.4.5.1 Spain Pyrogen Testing Market, by Product & Service
    - 7.2.4.5.2 Spain Pyrogen Testing Market, by Test Type
    - 7.2.4.5.3 Spain Pyrogen Testing Market, by End User
  - 7.2.4.6 Italy Pyrogen Testing Market
    - 7.2.4.6.1 Italy Pyrogen Testing Market, by Product & Service
    - 7.2.4.6.2 Italy Pyrogen Testing Market, by Test Type
    - 7.2.4.6.3 Italy Pyrogen Testing Market, by End User
  - 7.2.4.7 Rest of Europe Pyrogen Testing Market
    - 7.2.4.7.1 Rest of Europe Pyrogen Testing Market, by Product & Service
    - 7.2.4.7.2 Rest of Europe Pyrogen Testing Market, by Test Type
    - 7.2.4.7.3 Rest of Europe Pyrogen Testing Market, by End User
7.3 Asia Pacific Pyrogen Testing Market
- 7.3.1 Asia Pacific Pyrogen Testing Market, by Product & Service
  - 7.3.1.1 Asia Pacific Reagents & Kits Market, by Country
  - 7.3.1.2 Asia Pacific Services Market, by Country
  - 7.3.1.3 Asia Pacific Instruments Market, by Country
- 7.3.2 Asia Pacific Pyrogen Testing Market, by Test Type
  - 7.3.2.1 Asia Pacific LAL Test Market, by Country
  - 7.3.2.2 Asia Pacific Rabbit Pyrogen Test Market, by Country
  - 7.3.2.3 Asia Pacific Others Market, by Country
- 7.3.3 Asia Pacific Pyrogen Testing Market, by End User
  - 7.3.3.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market, by Country
  - 7.3.3.2 Asia Pacific Medical Device Companies Market, by Country
  - 7.3.3.3 Asia Pacific Others Market, by Country
- 7.3.4 Asia Pacific Pyrogen Testing Market, by Country
  - 7.3.4.1 China Pyrogen Testing Market
    - 7.3.4.1.1 China Pyrogen Testing Market, by Product & Service
    - 7.3.4.1.2 China Pyrogen Testing Market, by Test Type
    - 7.3.4.1.3 China Pyrogen Testing Market, by End User
  - 7.3.4.2 Japan Pyrogen Testing Market
    - 7.3.4.2.1 Japan Pyrogen Testing Market, by Product & Service
    - 7.3.4.2.2 Japan Pyrogen Testing Market, by Test Type
    - 7.3.4.2.3 Japan Pyrogen Testing Market, by End User
  - 7.3.4.3 India Pyrogen Testing Market
    - 7.3.4.3.1 India Pyrogen Testing Market, by Product & Service
    - 7.3.4.3.2 India Pyrogen Testing Market, by Test Type
    - 7.3.4.3.3 India Pyrogen Testing Market, by End User
  - 7.3.4.4 South Korea Pyrogen Testing Market
    - 7.3.4.4.1 South Korea Pyrogen Testing Market, by Product & Service
    - 7.3.4.4.2 South Korea Pyrogen Testing Market, by Test Type
    - 7.3.4.4.3 South Korea Pyrogen Testing Market, by End User
  - 7.3.4.5 Singapore Pyrogen Testing Market
    - 7.3.4.5.1 Singapore Pyrogen Testing Market, by Product & Service
    - 7.3.4.5.2 Singapore Pyrogen Testing Market, by Test Type
    - 7.3.4.5.3 Singapore Pyrogen Testing Market, by End User
  - 7.3.4.6 Malaysia Pyrogen Testing Market
    - 7.3.4.6.1 Malaysia Pyrogen Testing Market, by Product & Service
    - 7.3.4.6.2 Malaysia Pyrogen Testing Market, by Test Type
    - 7.3.4.6.3 Malaysia Pyrogen Testing Market, by End User
  - 7.3.4.7 Rest of Asia Pacific Pyrogen Testing Market
    - 7.3.4.7.1 Rest of Asia Pacific Pyrogen Testing Market, by Product & Service
    - 7.3.4.7.2 Rest of Asia Pacific Pyrogen Testing Market, by Test Type
    - 7.3.4.7.3 Rest of Asia Pacific Pyrogen Testing Market, by End User
7.4 LAMEA Pyrogen Testing Market
- 7.4.1 LAMEA Pyrogen Testing Market, by Product & Service
  - 7.4.1.1 LAMEA Reagents & Kits Market, by Country
  - 7.4.1.2 LAMEA Services Market, by Country
  - 7.4.1.3 LAMEA Instruments Market, by Country
- 7.4.2 LAMEA Pyrogen Testing Market, by Test Type
  - 7.4.2.1 LAMEA LAL Test Market, by Country
  - 7.4.2.2 LAMEA Rabbit Pyrogen Test Market, by Country
  - 7.4.2.3 LAMEA Others Market, by Country
- 7.4.3 LAMEA Pyrogen Testing Market, by End User
  - 7.4.3.1 LAMEA Pharmaceutical & Biotechnology Companies Market, by Country
  - 7.4.3.2 LAMEA Medical Device Companies Market, by Country
  - 7.4.3.3 LAMEA Others Market, by Country
- 7.4.4 LAMEA Pyrogen Testing Market, by Country
  - 7.4.4.1 Brazil Pyrogen Testing Market
    - 7.4.4.1.1 Brazil Pyrogen Testing Market, by Product & Service
    - 7.4.4.1.2 Brazil Pyrogen Testing Market, by Test Type
    - 7.4.4.1.3 Brazil Pyrogen Testing Market, by End User
  - 7.4.4.2 Argentina Pyrogen Testing Market
    - 7.4.4.2.1 Argentina Pyrogen Testing Market, by Product & Service
    - 7.4.4.2.2 Argentina Pyrogen Testing Market, by Test Type
    - 7.4.4.2.3 Argentina Pyrogen Testing Market, by End User
  - 7.4.4.3 UAE Pyrogen Testing Market
    - 7.4.4.3.1 UAE Pyrogen Testing Market, by Product & Service
    - 7.4.4.3.2 UAE Pyrogen Testing Market, by Test Type
    - 7.4.4.3.3 UAE Pyrogen Testing Market, by End User
  - 7.4.4.4 Saudi Arabia Pyrogen Testing Market
    - 7.4.4.4.1 Saudi Arabia Pyrogen Testing Market, by Product & Service
    - 7.4.4.4.2 Saudi Arabia Pyrogen Testing Market, by Test Type
    - 7.4.4.4.3 Saudi Arabia Pyrogen Testing Market, by End User
  - 7.4.4.5 South Africa Pyrogen Testing Market
    - 7.4.4.5.1 South Africa Pyrogen Testing Market, by Product & Service
    - 7.4.4.5.2 South Africa Pyrogen Testing Market, by Test Type
    - 7.4.4.5.3 South Africa Pyrogen Testing Market, by End User
  - 7.4.4.6 Nigeria Pyrogen Testing Market
    - 7.4.4.6.1 Nigeria Pyrogen Testing Market, by Product & Service
    - 7.4.4.6.2 Nigeria Pyrogen Testing Market, by Test Type
    - 7.4.4.6.3 Nigeria Pyrogen Testing Market, by End User
  - 7.4.4.7 Rest of LAMEA Pyrogen Testing Market
    - 7.4.4.7.1 Rest of LAMEA Pyrogen Testing Market, by Product & Service
    - 7.4.4.7.2 Rest of LAMEA Pyrogen Testing Market, by Test Type
    - 7.4.4.7.3 Rest of LAMEA Pyrogen Testing Market, by End User

Chapter 8. Company Profiles

8.1 Merck KGaA
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Charles River Laboratories International, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Recent strategies and developments:
  - 8.2.4.1 Product Launches and Product Expansions:
  - 8.2.4.2 Acquisition and Mergers:
- 8.2.5 SWOT Analysis
8.3 Genscript Biotech Corporation
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional & Segmental Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
8.4 WuXi AppTec Co., Ltd.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental Analysis
- 8.4.4 Research & Development Expenses
8.5 Lonza Group Ltd.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Partnerships, Collaborations, and Agreements:
  - 8.5.5.2 Product Launches and Product Expansions:
- 8.5.6 SWOT Analysis
8.6 Fujifilm Holdings Corporation
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
8.7 Eurofins Scientific SE
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Regional Analysis
- 8.7.4 SWOT Analysis
8.8 Thermo Fisher Scientific, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expenses
- 8.8.5 SWOT Analysis
8.9 Seikagaku Corp.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental Analysis
- 8.9.4 Research & Development Expenses
- 8.9.5 SWOT Analysis
8.10. InvivoGen SAS
- 8.10.1 Company Overview
- 8.10.2 SWOT Analysis

한글목차

목차

제1장 시장 범위와 조사 방법

제2장 시장 요약

제3장 시장 개요

제4장 세계 시장 : 제품 및 서비스별

제5장 세계 시장 : 시험 유형별

제6장 세계 시장 : 최종사용자별

제7장 세계 시장 : 지역별